Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Pertussis
2020
2014
Americas
Clear all
Type of publications
NITAG documentation
(73)
Systematic reviews (SYSVAC)
(6)
Topics
Available to download in languages
Regions
Americas
(79)
Africa
(5)
Europe
(32)
South-East Asia
(1)
Western Pacific
(20)
Countries
Argentina
(1)
Brazil
(1)
Canada
(6)
Chile
(9)
United States of America
(61)
Diseases
COVID-19
(62)
Human papillomavirus (HPV)
(13)
Pertussis
(4)
Diphtheria
(2)
Haemophilus influenzae type B
(1)
Hepatitis A
(2)
Influenza
(13)
Meningococcal disease
(6)
Pneumococcal disease
(4)
Tetanus
(1)
Typhoid
(1)
Varicella
(1)
Vaccine topics
Acceptance
(4)
Coverage
(5)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Target population
Adolescents
(6)
Adults
(5)
Healthcare workers
(5)
Older adults
(1)
Parents/caregivers
(3)
Risk group
(3)
Publication date
2020
(66)
2014
(13)
2024
(1)
2023
(12)
2022
(47)
2021
(68)
2019
(10)
2018
(10)
2017
(4)
2016
(13)
2015
(8)
2013
(3)
2012
(1)
2011
(1)
2010
(2)
2009
(3)
2007
(1)
2005
(1)
79 results found
2020
∙
Vu, M. Berg, C. J. Escoffery, C. Jang, H. M. Nguyen, T. T. Travis, L. Bednarczyk, R. A.
A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans’ human papillomavirus vaccine intention and uptake
2020
∙
Avni-Singer, L. R. Yakely, A. Sheth, S. S. Shapiro, E. D. Niccolai, L. M. Oliveira, C. R.
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
2020
∙
Rodriguez, S. A. Mullen, P. D. Lopez, D. M. Savas, L. S. Fernandez, M. E.
Factors associated with adolescent HPV vaccination in the U.S.: A systematic review of reviews and multilevel framework to inform intervention development
2020
∙
CAVEI
CAVEI recommendation to prioritize vaccination against SARS-COV-2 in people over 65 years in the context of limited supply of vaccines
2020
∙
Melinda Wharton, ACIP
ACIP COVID-19 Vaccine Safety Technical Sub-Group
2020
∙
Beth Bell, ACIP
ACIP COVID-19 Vaccines Work Group - overview of American vaccines in development
2020
∙
Thomas Clark, ACIP
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
2020
∙
William Gruber, ACIP
BNT162b2 Vaccine Candidate Against COVID-19
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI Interim statement on target groups for vaccination against SARS-COV-2
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register